Houston Methodist and One Medical Announce Partnership Focused on Seamless Coordinated Care
HOUSTON and SAN FRANCISCO, Sept. 30, 2020 (GLOBE NEWSWIRE) — With a shared commitment to transforming the healthcare experience, Houston […]
Axogen, Inc. Appoints Paul G. Thomas to Board of Directors
Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of DirectorsALACHUA, Fla., Sept. 30, 2020 (GLOBE NEWSWIRE) […]
G1 Therapeutics Announces Chief Executive Officer Succession Plan
– Mark Velleca, M.D., Ph.D., G1’s first Chief Executive Officer, to serve as senior advisor and remain member of the […]
Bank OZK Announces Date for Third Quarter 2020 Earnings Release and Conference Call
LITTLE ROCK, Ark., Sept. 30, 2020 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) expects to report third quarter […]
Landmark Infrastructure Partners LP Announces Completion of Digital Infrastructure Acquisitions
EL SEGUNDO, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership” or “Landmark”) (NASDAQ: LMRK) announced […]
LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach […]
Gear4 Introduces Protective Cases for New Google Pixel 4a 5G and Pixel 5 Phones
SALT LAKE CITY, Sept. 30, 2020 (GLOBE NEWSWIRE) — Gear4®, a ZAGG Brands (NASDAQ:ZAGG) company, today announced the Crystal Palace […]
InvisibleShield Introduces Glass Screen Protection for the Google Pixel 4a 5G and Pixel 5 Smartphones
SALT LAKE CITY, Sept. 30, 2020 (GLOBE NEWSWIRE) — InvisibleShield®, a ZAGG Brands (NASDAQ:ZAGG) company and the leading global innovator […]
Exela Receives Star Performer Designation in Everest Group’s PEAK Matrix for Revenue Cycle Management (RCM) Operations
IRVING, Texas, Sept. 30, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA) today announced that it was recently […]
Soleno Therapeutics Announces Updated Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
Updated Results Demonstrate Significant DCCR Exposure Response RelationshipInterim Analysis of Open-Label Extension Data Demonstrate Continued EfficacyImprovements in Body Composition and […]
